Monday, August 24, 2026

Korean Pitcher Go Woo-suk Suspended for 10 Games: What Happened?

Minnesota Twins pitcher Go Woo-suk faces a 10-game suspension for using a foreign substance during a game, complicating his MLB prospects.

American Investors Turn to Korean Equities as AI Boom Lifts KOSPI Toward 8,000

The KOSPI index nears 8,000 as U.S. investors flock to Korean stocks, with AI-driven gains in Samsung and SK Hynix.

Tariffs 15% to 25%: Trump Move Heads for the Federal Register as Seoul Scrambles to Pass U.S. Investment Law by Next Month

President Trump's 25% tariff on Korean imports sparks urgent negotiations and political maneuvering in South Korea's National Assembly.

Tag: Imeroprubart

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

Is A Breakthrough For Thyroid Eye Disease Still Out Of Reach?

HanAll Biopharma's Phase 3 trial of batoclimab for Thyroid Eye Disease failed to show statistical significance, but safety profiles remain consistent.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.